Document 0604 DOCN M9550604 TI Regulation of I kappa B alpha and p105 in monocytes and macrophages persistently infected with human immunodeficiency virus. DT 9505 AU McElhinny JA; MacMorran WS; Bren GD; Ten RM; Israel A; Paya CV; Department of Immunology, Mayo Clinic, Rochester, Minnesota; 55905. SO J Virol. 1995 Mar;69(3):1500-9. Unique Identifier : AIDSLINE MED/95156575 AB The mechanisms regulating human immunodeficiency virus (HIV) persistence in human monocytes/macrophages are partially understood. Persistent HIV infection of U937 monocytic cells results in NF-kappa B activation. Whether virus-induced NF-kappa B activation is a mechanism that favors continuous viral replication in macrophages remains unknown. To further delineate the molecular mechanisms involved in the activation of NF-kappa B in HIV-infected monocytes and macrophages, we have focused on the regulation of the I kappa B molecules. First, we show that persistent HIV infection results in the activation of NF-kappa B not only in monocytic cells but also in macrophages. In HIV-infected cells, I kappa B alpha protein levels are decreased secondary to enhanced protein degradation. This parallels the increased I kappa B alpha synthesis secondary to increased I kappa B alpha gene transcription, i.e., increased RNA and transcriptional activity of its promoter-enhancer. Another protein with I kappa B function, p105, is also modified in HIV-infected cells: p105 and p50 steady-state protein levels are increased as a result of increased synthesis and proteolytic processing of p105. Transcriptional activity of p105 is also increased in infected cells and is also mediated by NF-kappa B through a specific kappa B motif. These results demonstrate the existence of a triple autoregulatory loop in monocytes and macrophages involving HIV, p105 and p50, and MAD3, with the end result of persistent NF-kappa B activation and viral persistence. Furthermore, persistent HIV infection of monocytes and macrophages provides a useful model with which to study concomitant modifications of different I kappa B molecules. DE Base Sequence Cell Line DNA Primers/CHEMISTRY Enhancer Elements (Genetics) Gene Expression Regulation, Viral Human HIV Infections/*GENETICS HIV-1/GENETICS In Vitro Macrophages/*MICROBIOLOGY Molecular Sequence Data Monocytes/*MICROBIOLOGY NF-kappa B/*METABOLISM Promoter Regions (Genetics) Proto-Oncogene Proteins/*METABOLISM RNA, Messenger/GENETICS Support, Non-U.S. Gov't Support, U.S. Gov't, P.H.S. Transcription, Genetic JOURNAL ARTICLE SOURCE: National Library of Medicine. NOTICE: This material may be protected by Copyright Law (Title 17, U.S.Code).